Normal serum matrix metalloproteinase-3 levels can be used to predict clinical remission and normal physical function in patients with rheumatoid arthritis

MLA

Daihei Kida, et al. “Normal Serum Matrix Metalloproteinase-3 Levels Can Be Used to Predict Clinical Remission and Normal Physical Function in Patients with Rheumatoid Arthritis.” Clinical Rheumatology, vol. 38, no. 1, Aug. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b0d8c8c8f4d288f6cf2022cb60dadb91&authtype=sso&custid=ns315887.

APA

Daihei Kida, Atsushi Kaneko, & Yosuke Hattori. (2017). Normal serum matrix metalloproteinase-3 levels can be used to predict clinical remission and normal physical function in patients with rheumatoid arthritis. Clinical Rheumatology, 38(1).

Chicago

Daihei Kida, Atsushi Kaneko, and Yosuke Hattori. 2017. “Normal Serum Matrix Metalloproteinase-3 Levels Can Be Used to Predict Clinical Remission and Normal Physical Function in Patients with Rheumatoid Arthritis.” Clinical Rheumatology 38 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b0d8c8c8f4d288f6cf2022cb60dadb91&authtype=sso&custid=ns315887.